1. Chemical & Biological Defense Program Science & Technology
COL Ben Hagar
Deputy, Joint Science & Technology Office for CB Defense
Defense Threat Reduction Agency
JSTO

2. Overview
Continued strong Department and Congressional support for CBDP S&T
Strengthened ability to transition from DARPA programs
DTRA re-aligning its R&D efforts
STRATCOM Combating WMD role
JSTO

3. Preserving warfighter effectiveness through medical countermeasures
Transition
Technologies
Answer
Science
Questions
Maintain
Robust
Tech Base
Diagnostics
Pretreatments/
Prophylaxes
Emerging Threats/
Special Programs
Therapeutics
JSTO

4. Modeling and Simulation
Preserving warfighter effectiveness with advanced equipment and materials
Protection
Decontamination
Detection
Transition
Technologies
Answer
Science
Questions
Maintain
Robust
Tech Base
Modeling and Simulation
Supporting S&T
JSTO

5. Principle “Plain Language” Thrusts
Earliest Warning
Detection
Medical Surveillance
Information Dissemination
Broad Spectrum Medical Countermeasures
Pretreatment
Therapeutics
“How Clean is Safe?”
Decontamination
Low-Level Toxicology
Environmental Fate of Agent
JSTO

6. Medical CB S&T Strategy
Place greater emphasis on developing medical countermeasures effective against a broader range of pathogens to mitigate novel agent effects
Accelerate development cycle (rapid vaccine and drug development)
Exploit cutting edge technologies to improve medical countermeasures against established high-priority CB agents and against emerging CB agents and effects
Leverage existing capability found in other federal agencies, industry, and international partners
Sustain long-term investment in developing candidates for capability gaps
Ensure knowledge base to support future technology development
JSTO

7. Physical S&T program strategy
Balance between requirements pull:
Align with the JRO to address capability needs
Align with JPEO programs to address technology gaps
Answer critical science questions that support policy, doctrine and requirements decisions
… and technology push:
Centralize investment in basic research (6.1)
Identify and exploit technology opportunities
Identify and respond to new and emerging threats
Transition new and innovative technologies with JPEO
Maintain a robust technology base: knowledge, research capabilities, and test and evaluation methodologies
JSTO

8. How we have changed the Physical S&T business strategy …
Find and Fund the Best Performers:
Maintain an active outreach to a broad base of potential performers in government, academia, and industry
Emphasize teaming and comprehensive approaches
Allow the best ideas to emerge through competition
Select the best science and most innovative ideas: no favorites, no quotas
Exploit Cutting Edge Technologies:
Find and fund new cross-cutting technologies
Leverage new ideas from other sources
Sustain Long-Term Investment:
Fund promising technologies from concept through transition
Our business strategy is to leverage as much technology as possible from other sources such as DARPA, HSARPA and other agencies, and I have formed a Special Projects Office in my Division to do this.
Our approach for new projects is to select the best performers with the best science regardless of their affiliation - no favorites and no quotas. Such projects will be funded from concept to transition within a 3-4 year timeframe.
JSTO

9. …and developed an overarching science strategy …
Build a Fundamental Understanding of CB Agents:
Physical and chemical properties
Fundamental interactions with other materials and environment
Pathological and toxicological properties
Exploitable signatures
Leverage Advancements in Strategic Research:
Develop Revolutionary Solutions:
Integrated system for complete knowledge of the CB environment
Unencumbering full protection
Rapid inactivation of CB hazards
Information dominance
Nanoscience
Bioengineering sciences
Multifunctional materials
Human performance science
JSTO

10. FY06 Core Funding Increases
FY05($M)
FY06($M)
Increase
CB.1
6.3
15.7
150%
CB.2
62.1
104.3
68%
CB.3
39.9
60.8
53%
Total
108.2
180.8
67%
Detection
33.9
43.9
30%
MSB
9.1
38.4
324%
Protection
9.6
19.7
106%
Decon
5.2
8.9
71%
TAS
31.0
32.8 6%
JSTO

11. Scientific Challenges
Develop a fundamental understanding of properties and mechanisms underlying EM detection of CB agents in order to better identify and predict unique and distinguishable signatures
Formulate optimal filters for fusion of disparate sensor information in non-linear dynamic networks
Discover new materials that are sorbent and/or stably reactive which provide order-of-magnitude CB agent removal rates and capacity over current activated carbon technologies
Develop a fundamental understanding of CB agent and decontaminant transport in solid substrates to predict agent fate, removal efficacy (or neutralization), and material effects
JSTO